Search Results - "antiviral"

LC-ESI/MS-Phytochemical Profiling with Antioxidant, Antibacterial, Antifungal, Antiviral and In Silico Pharmacological Properties of Algerian <i>Asphodelus tenuifolius</i> (Cav.)... by Ayoub Khalfaoui, Emira Noumi, Soumia Belaabed, Kaïss Aouadi, Bouslama Lamjed, Mohd Adnan, Andrea Defant, Adel Kadri, Mejdi Snoussi, Mushtaq Ahmad Khan, Ines Mancini

Connect to this object online.

A Dual-Functioning 5ʹ-PPP-NS1shRNA that Activates a RIG-I Antiviral Pathway and Suppresses Influenza NS1 by Neetu Singh, Priya Ranjan, Weiping Cao, Jenish Patel, Shivaprakash Gangappa, Bruce A. Davidson, John M. Sullivan, Paras N. Prasad, Paul R. Knight, Suryaprakash Sambhara

Connect to this object online.

Molecular detection of hepatitis B virus genotype E with immune escape mutations in chronic hepatitis B patients on long-term antiviral therapy in Jos, Nigeria by Joseph Anejo-Okopi, Edith Okeke, Pantong M. Davwar, Chika Onwuamah, Harris Onywera, Patience Omaiye, Mary Duguru, Ocheme J. Okojokwu, Otobo I. Ujah, Bulus Jonathan, Chima A. George, Ramyil S. Crown, Fiyaktu B. Yakubu, Judith O. Sokei, Leona C. Okoli, Onyemocho Audu, Seth C. Inzaule, Isaac O. Abah, Patricia Agaba, Oche O. Agbaji, Atiene S. Sagay, Claudia Hawkins

Connect to this object online.

Effectiveness of triple therapy with direct-acting antivirals for hepatitis C genotype 1 infection: application of propensity score matching in a national HCV treatment registry by Emma Gray, David J. Pasta, Suzanne Norris, Aisling O'Leary, on behalf of the Irish Hepatitis C Outcomes and Research Network (ICORN)

Connect to this object online.

Combination of the parent analogue of remdesivir (GS-441524) and molnupiravir results in a markedly potent antiviral effect in SARS-CoV-2 infected Syrian hamsters by Rana Abdelnabi, Rana Abdelnabi, Piet Maes, Piet Maes, Steven de Jonghe, Birgit Weynand, Johan Neyts, Johan Neyts, Johan Neyts

Connect to this object online.

Treatment of HCV with direct-acting antivirals on reducing mortality related to extrahepatic manifestations: a large population-based study in British Columbia, CanadaResearch in context by Dahn Jeong, Stanley Wong, Mohammad Ehsanul Karim, Amee R. Manges, Jean Damascene Makuza, Sofia R. Bartlett, Héctor Alexander Velásquez García, Daryl Luster, Prince Asumadu Adu, Mawuena Binka, Amanda Yu, Mel Krajden, Naveed Zafar Janjua

Connect to this object online.

Evaluation of antiviral activity of Ocimum sanctum and Acacia arabica leaves extracts against H9N2 virus using embryonated chicken egg model by S. S. Ghoke, R. Sood, N. Kumar, A. K. Pateriya, S. Bhatia, A. Mishra, R. Dixit, V. K. Singh, D. N. Desai, D. D. Kulkarni, U. Dimri, V. P. Singh

Connect to this object online.

Deciphering antiviral efficacy of malaria box compounds against malaria exacerbating viral pathogens- Epstein Barr virus and SARS-CoV-2, an in silico study by Omkar Indari, Ajit Kumar Singh, Deeksha Tiwari, Hem Chandra Jha, Anupam Nath Jha

Connect to this object online.

Efficacy and Safety of Direct-Acting Antiviral Therapy in Patients With Chronic Hepatitis C Virus Infection: A Real-World Single-Center Experience in Tianjin, China by Huan Xia, Chengzhen Lu, Yin Wang, Silvere D. Zaongo, Silvere D. Zaongo, Yue Hu, Yue Wu, Zhongfang Yan, Ping Ma

Connect to this object online.

'Poly phenolic phytoceutical loaded nano-bilosomes for enhanced caco-2 cell permeability and SARS-CoV 2 antiviral activity': in-vitro and insilico studies by Mohamed Y. Zakaria, Shady M. Abd El-Halim, Botros Y. Beshay, Islam Zaki, Mohammed A.S Abourehab

Connect to this object online.

Heparin Precursors with Reduced Anticoagulant Properties Retain Antiviral and Protective Effects That Potentiate the Efficacy of Sofosbuvir against Zika Virus Infection in Human Neural Progenitor Cells by Isabel Pagani, Linda Ottoboni, Paola Panina-Bordignon, Gianvito Martino, Guido Poli, Sarah Taylor, Jeremy E. Turnbull, Edwin Yates, Elisa Vicenzi

Connect to this object online.

The allocation of COVID-19 vaccines and antivirals against emerging SARS-CoV-2 variants of concern in East Asia and Pacific region: A modelling study by Kathy Leung, Mark Jit, Gabriel M Leung, Joseph T Wu

Connect to this object online.

Impact of extending direct antiviral agents (DAA) availability in France: an observational cohort study (2015-2019) of data from French administrative healthcare databases (SNDS). by Stanislas Pol, Fayssoil Fouad, Magali Lemaitre, Ingrid Rodriguez, Olivier Lada, Pascaline Rabiega, Elias Benabadji, Françoise Roudot-Thoraval

Connect to this object online.

A randomized, double-blind, placebo-controlled phase 1 trial of inhaled and intranasal niclosamide: A broad spectrum antiviral candidate for treatment of COVID-19 by Vibeke Backer, Ulf Sjöbring, Jesper Sonne, Anne Weiss, Morten Hostrup, Helle Krogh Johansen, Victoria Becker, David P. Sonne, Torben Balchen, Mads Jellingsø, Morten Otto Alexander Sommer

Connect to this object online.

Pulmonary delivery of favipiravir inhalation solution for COVID-19 treatment: in vitro characterization, stability, in vitro cytotoxicity, and antiviral activity using real time cell analysis by Ayca Yildiz Pekoz, Ozlem Akbal Dagistan, Hanan Fael, Meltem Culha, Aybige Erturk, Nur Sena Basarir, Gokben Sahin, Muge Serhatli, Gamze Cakirca, Saban Tekin, Leyla Semiha Sen, Mustafa Sevim, Lutfiye Mulazimoglu Durmusoglu, Berrak C. Yegen

Connect to this object online.

MicroRNA profiling of human primary macrophages exposed to dengue virus identifies miRNA-3614-5p as antiviral and regulator of ADAR1 expression. by Mayra Diosa-Toro, Liliana Echavarría-Consuegra, Jacky Flipse, Geysson Javier Fernández, Joost Kluiver, Anke van den Berg, Silvio Urcuqui-Inchima, Jolanda M Smit

Connect to this object online.

Seminal parameters before and during combined antiviral (pegylated interferon α-2a and ribavirin) treatment in chronic hepatitis C virus patients in upper Egypt by Hussein M Ghanem, Nashaat N Ismaeel, Alaa F Haseeb, Waleed M Nabawy, Mohamed Rehan, Hala Shreen

Connect to this object online.

A systematic review and meta-analysis of community and primary-care-based hepatitis C testing and treatment services that employ direct acting antiviral drug treatments by Andrew Radley, Emma Robinson, Esther J. Aspinall, Kathryn Angus, Lex Tan, John F. Dillon

Connect to this object online.

Could chlorophyllins improve the safety profile of beta-d-N4-hydroxycytidine versus N-hydroxycytidine, the active ingredient of the SARS-CoV-2 antiviral molnupiravir? by Nicole F. Clark, Andrew W. Taylor-Robinson, Kirsten Heimann

Connect to this object online.

Synthesis and Antiviral Activity of Novel β-D-N4-Hydroxycytidine Ester Prodrugs as Potential Compounds for the Treatment of SARS-CoV-2 and Other Human Coronaviruses by Elizaveta S. Darnotuk, Andrei E. Siniavin, Natal'ya S. Shastina, Sergey I. Luyksaar, Anna M. Inshakova, Natalia E. Bondareva, Sergey A. Zolotov, Nadezhda L. Lubenec, Anna B. Sheremet, Denis Y. Logunov, Nailya A. Zigangirova, Vladimir A. Gushchin, Alexander L. Gintsburg

Connect to this object online.